LAZARD ASSET MANAGEMENT LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 6.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$25
+400.0%
4,596
+245.6%
0.00%
Q1 2024$5
-54.5%
1,330
-49.6%
0.00%
Q4 2023$11
-78.0%
2,637
-77.4%
0.00%
Q3 2023$50
-21.9%
11,684
+20.2%
0.00%
Q2 2023$64
+255.6%
9,718
+263.0%
0.00%
Q1 2023$18
-33.3%
2,677
-27.1%
0.00%
Q4 2022$27
-99.9%
3,6720.0%0.00%
Q3 2022$36,000
-10.0%
3,6720.0%0.00%
Q2 2022$40,000
-2.4%
3,6720.0%0.00%
Q1 2022$41,000
-29.3%
3,672
-0.8%
0.00%
Q4 2021$58,000
+5.5%
3,700
+14.9%
0.00%
Q3 2021$55,000
-27.6%
3,219
-9.2%
0.00%
Q2 2021$76,000
+43.4%
3,5470.0%0.00%
Q1 2021$53,000
+60.6%
3,547
+37.3%
0.00%
Q4 2020$33,000
+371.4%
2,584
+231.7%
0.00%
Q3 2020$7,000
-82.9%
779
-78.4%
0.00%
Q2 2020$41,000
-40.6%
3,601
-46.0%
0.00%
Q1 2020$69,000
+40.8%
6,663
+122.1%
0.00%
Q4 2019$49,000
+188.2%
3,000
+131.5%
0.00%
Q3 2019$17,0001,2960.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 728,000$10,425,0005.01%
Signpost Capital Advisors, LP 828,793$11,868,0004.38%
Palo Alto Investors LP 3,786,908$54,229,0003.18%
RTW INVESTMENTS, LP 500,000$7,160,0002.65%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,139,787$59,282,0002.13%
First Light Asset Management, LLC 229,818$3,291,0001.86%
KINGDON CAPITAL MANAGEMENT, L.L.C. 2,461,305$35,246,0001.53%
PURA VIDA INVESTMENTS, LLC 175,000$2,506,0000.92%
WALL STREET ASSOCIATES 655,800$9,391,0000.90%
SPHERA FUNDS MANAGEMENT LTD. 368,390$5,275,0000.90%
View complete list of VANDA PHARMACEUTICALS INC shareholders